Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.143 USD | -2.05% | -7.74% | -26.67% |
15/04 | CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
05/03 | Transcript : CytoDyn Inc. - Special Call |
Sales 2022 | 0.27 22.18 | Sales 2023 | - | Capitalization | 239M 19.97B |
---|---|---|---|---|---|
Net income 2022 | -211M -17.59B | Net income 2023 | -79M -6.59B | EV / Sales 2022 | 98,95,24,989 x |
Net Debt 2022 | 32.57M 2.72B | Net Debt 2023 | 33.01M 2.75B | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.02
x | P/E ratio 2023 |
-2.52
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.15% |
Latest transcript on CytoDyn Inc.
1 day | -2.05% | ||
1 week | -7.74% | ||
Current month | -12.43% | ||
1 month | -14.17% | ||
3 months | -11.35% | ||
6 months | -15.88% | ||
Current year | -26.67% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 17/11 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | 01/02 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 03/23/03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 13/22/13 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 24/22/24 |
Karen Brunke
BRD | Director/Board Member | 72 | 01/22/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.143 | -2.05% | 2,217,125 |
25/24/25 | 0.146 | -1.68% | 420,675 |
24/24/24 | 0.1485 | -1.00% | 648,615 |
23/24/23 | 0.15 | -0.07% | 423,580 |
22/24/22 | 0.1501 | -3.16% | 790,017 |
Delayed Quote OTC Markets, April 27, 2024 at 01:29 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-26.67% | 142M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- CYDY Stock